Arbutus Biopharma (ABUS) Competitor Comparison
We are evaluating the key criteria listed to compare Arbutus Biopharma (ABUS) against its competitors in the Biotechnology industry.
Market Capitalization
173 / 368Gross Profits
192 / 278Total Revenue
159 / 300EBITDA
173 / 337Free Cashflow
206 / 352Quick Ratio
153 / 357Earnings per Share
76 / 359Dividend yield
0 / 6Total Cash
193 / 358Performance 3 years
91 / 368Performance 5 years
62 / 368Performance 10 years
198 / 368Linearity 3 years
16 / 368Linearity 5 years
259 / 368Linearity 10 years
233 / 368Total Rank
137 / 368Dividend Rank
355 / 368Valuation Rank
181 / 368Piotroski Rank
78 / 368Muliplier Rank
273 / 368Performance 5 years - ABUS ranking 62 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.